Microneedling devices have been increasingly used by medical practitioners for skin rejuvenation and scar treatment, and some devices are also available for patient use at home.^[@CIT0001]^ Reported side effects include pain, transient erythema, edema, bruising, pin-point bleeding and crusting, postinflammatory hyperpigmentation, and tram track scarring, the severity of which often depends on the needle length.^[@CIT0002],[@CIT0003]^ Local hypersensitivity reactions have also been reported in 4 patients.^[@CIT0004],[@CIT0005]^ Although the *stratum corneum* barrier is disrupted, there are no reports of associated infections to the knowledge of the authors. Herein, we report a case of an extensive *tinea corporis* with a bizarre distribution pattern associated with the use of a microneedling device.

A 26-year-old woman, otherwise healthy, presented to us in February 2014 with an itchy dermatosis evolving for one week and affecting both arms and both legs. On examination ([Figure 1](#F1){ref-type="fig"}), multiple annular erythematous plaques of 0.5 to 2 cm in diameter and elevated borders were observed on the anterior and posterior aspects of both forearms, the anterior aspect of both thighs, and the abdomen. Lesions on the forearms and thighs had emerged simultaneously and corresponded with sites where she had been using a microneedling device weekly at night for 3 weeks prior to the appearance of the dermatosis. The device was a dermaroller with 540 stainless steel microneedles of 0.5 mm length, and had been recommended to her by a dermatologist to treat old traumatic linear scars present on those areas. After the microneedling, she applied rosehip oil to her skin. The patient assured us she had carefully cleaned the skin beforehand, and the device before and after the procedure, using 70% ethanol. She said she had not used the device over any kind of previously existing inflammatory skin lesion.

![This 26-year-old woman presented to us with multiple annular erythematous plaques of 0.5 to 2 cm in diameter and elevated borders on both forearms, both thighs, and abdomen. The pictures, taken on the occasion she presented, show the posterior aspect of the right forearm (A), the anterior (B) and posterior (C) aspects of the left forearm, and the anterior aspect of both thighs (D). A close up of the lesions can be observed (E).](sjx08601){#F1}

The differential diagnoses considered were *tinea corporis*, *granuloma annulare*, and erythema *multiforme minor*. A cutaneous biopsy was performed and superficial scrapings were collected for mycological examination. A potassium hydroxide examination was positive for fungus, and the culture identified *Microsporum canis* as the causative agent. Subcorneal hyphae were seen on histology ([Figure 2](#F2){ref-type="fig"}).

![Histological examination of the skin biopsy, showing epidermal spongiosis, subcorneal neutrophils and hyphae, and a superficial perivascular lymphocytic infiltrate (A: hematoxylin-eosin stain, 100×; B: Periodic Acid-Schiff stain, 400×).](sjx08602){#F2}

The patient was effectively treated with oral terbinafine, 250 mg *per os* daily for one month, and topic sertoconazol, twice daily until complete resolution. At a three-week follow up, partial resolution was observed ([Figure 3](#F3){ref-type="fig"}), with complete resolution at the five-week follow up. Upon further questioning, the patient recalled that her cat, who often slept on her bed, had experienced tail desquamation and hair loss for 2 weeks before the onset of her dermatosis. Hence, she was also advised to seek a veterinary consultation for the cat. Unfortunately, we were not able to obtain a mycological examination of the cat's skin.

![Posterior aspect of both forearms (A) and anterior aspect of both thighs (B) of the same patient 3 weeks after starting the treatment with terbinafine 250 mg *per os* daily and topical sertaconazol twice daily. Great improvement was observed. The patient continued terbinafine for one more week, and topical sertaconazol until complete resolution.](sjx08603){#F3}

Considering the patient's anamnesis and this unusual pattern of *tinea corporis*, with simultaneously arising lesions in the sites where the microneedling device was applied, we can consider that the disruption of the epidermis by the microneedles facilitated the infection of multiple sites when in contact with the infected cat and/or bed linen. Microneedling dramatically increases the skin's permeability to therapeutic and cosmeceutical substances by creating reversible microchannels in the skin.^[@CIT0006],[@CIT0007]^ This enhanced permeability was shown to be optimal at 5 minutes after microneedling with 1 mm long needles, and drastically reduced after 30 minutes.^[@CIT0006]^ Similarly, while open, these microchannels may facilitate the access of microorganisms or deleterious substances.^[@CIT0006]^ The exact depth of needle penetration and the effects on skin permeability with the device used by the patient may differ from those results due to a higher density of shorter needles and variations in the pressure used. Nevertheless, in superficial mycoses, fungi invade keratinized tissues, so even if the depth of the microchannels is eventually smaller, the disruption of the *stratum corneum* is sufficient to facilitate a fungal infection. As the procedure was performed by the patient, a less rigorous pre- and postprocedural care with the device cannot be excluded, and might be an important additional factor.

Microneedling is a minimally invasive procedure, with a low risk of complications.^[@CIT0001],[@CIT0002],[@CIT0006],[@CIT0007]^ However, even if it remains relatively intact, the epidermis is indeed disrupted, and this may predispose to cutaneous infections. This case report emphasizes the critical need for standardized protocols for safe microneedling techniques, specific regulatory guidelines for home vs medical usage, and avoidance of inadvertent exposure to infectious agents in the treatment environment. We strongly advise that patients be informed of the appropriate care with homecare rollers and to avoid undue exposure to contaminants during the critical period for reestablishment of the skin's barrier system. These concerns should apply equally to motorized devices and treatments in medical facilities. Although microneedling is usually a safe procedure, technical expertise during the procedure and vigilant proactive aftercare are essential to obtain successful outcomes and should be mandatory.
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